Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-73.22%
operating margin TTM
-91.57%
revenue TTM
27.45 Thousand
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -0.04 |
| peg ratio | 0.00 |
| price to book ratio | 0.11 |
| price to sales ratio | 0.12 |
| enterprise value multiple | 1.18 |
| price fair value | 0.11 |
profitability ratios | |
|---|---|
| gross profit margin | 95.91% |
| operating profit margin | -91.57% |
| pretax profit margin | -77.85% |
| net profit margin | -73.22% |
| return on assets | -18.39% |
| return on equity | -142.16% |
| return on capital employed | -75.79% |
liquidity ratios | |
|---|---|
| current ratio | 0.06 |
| quick ratio | 0.06 |
| cash ratio | 0.04 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 1.00 |
| days of payables outstanding | 14,101.78 |
| cash conversion cycle | -14,100.78 |
| receivables turnover | 364.27 |
| payables turnover | 0.03 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.25 |
| debt equity ratio | 0.88 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.47 |
| interest coverage | -17.08 |
| cash flow to debt ratio | -1.85 |
cash flow ratios | |
|---|---|
| free cash flow per share | -34.71 |
| cash per share | 2.12 |
| operating cash flow per share | -34.71 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.85 |
| short term coverage ratios | -1.85 |
| capital expenditure coverage ratio | -6,068,411.00 |
Frequently Asked Questions
When was the last time HCW Biologics Inc. (NASDAQ:HCWB) reported earnings?
HCW Biologics Inc. (HCWB) published its most recent earnings results on 14-08-2026.
What is HCW Biologics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. HCW Biologics Inc. (NASDAQ:HCWB)'s trailing twelve months ROE is -142.16%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. HCW Biologics Inc. (HCWB) currently has a ROA of -18.39%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HCWB's net profit margin stand at?
HCWB reported a profit margin of -73.22% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HCWB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.06 in the most recent quarter. The quick ratio stood at 0.06, with a Debt/Eq ratio of 0.88.